Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02835729
Title A Study of Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NewLink Genetics Corporation

acute myeloid leukemia


Cytarabine + Idarubicin

Cytarabine + Idarubicin + Indoximod

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.